Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Milton

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Clinical Nuclear Medicine|February 2, 2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra TherapyElba C Etchebehere, John C Araujo, Denái R Milton, et al.
Cancer|December 15, 2023
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutationsFatma Nihan Akkoc Mustafayev, Mihir Amitabh Shukla, Amanda Lanier, et al.
Journal of Surgical Oncology|July 15, 2024
Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinomaKyle G Mitchell, Hope Feldman, Denái R Milton, et al.
Human Pathology|March 22, 2016
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expressionKumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2017
Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell TransplantationAimee E Hammerstrom, Lindsey R Lombardi, Sai Ravi Pingali, et al.
Melanoma Research|January 25, 2017
Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progressionJunna Oba, Bita Esmaeli, Julie A Ellerhorst, et al.
Neuro-Oncology Advances|June 27, 2025
Molecular alterations in <i>IDH</i>-mutant astrocytoma: A multi-institutional retrospective studyKeng Lam, Hanim I Ozkizilkaya, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid MalignanciesIssa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Journal of Cutaneous Pathology|July 6, 2022
Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesionsAimi T Rothrock, Carlos A Torres-Cabala, Denái R Milton, et al.
Pigment Cell & Melanoma Research|January 24, 2016
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progressionSun-Hee Kim, Yuuri Hashimoto, Sung-Nam Cho, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Clinical Nuclear Medicine|February 2, 2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra TherapyElba C Etchebehere, John C Araujo, Denái R Milton, et al.
Cancer|December 15, 2023
Survival outcomes of patients with HER2/neu-positive breast cancer with germline BRCA mutationsFatma Nihan Akkoc Mustafayev, Mihir Amitabh Shukla, Amanda Lanier, et al.
Journal of Surgical Oncology|July 15, 2024
Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinomaKyle G Mitchell, Hope Feldman, Denái R Milton, et al.
Human Pathology|March 22, 2016
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expressionKumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2017
Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell TransplantationAimee E Hammerstrom, Lindsey R Lombardi, Sai Ravi Pingali, et al.
Melanoma Research|January 25, 2017
Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progressionJunna Oba, Bita Esmaeli, Julie A Ellerhorst, et al.
Neuro-Oncology Advances|June 27, 2025
Molecular alterations in <i>IDH</i>-mutant astrocytoma: A multi-institutional retrospective studyKeng Lam, Hanim I Ozkizilkaya, Denái R Milton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid MalignanciesIssa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Journal of Cutaneous Pathology|July 6, 2022
Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesionsAimi T Rothrock, Carlos A Torres-Cabala, Denái R Milton, et al.
Pigment Cell & Melanoma Research|January 24, 2016
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progressionSun-Hee Kim, Yuuri Hashimoto, Sung-Nam Cho, et al.
Pageof 19